Juva Life Highlights Q1 2022 Financials Showing 97% Increase in Revenue
Ryan Allway July 19th, 2022 News, Top News Company Reports Its Q1 2022 Results and Provides Comments on Operations VANCOUVER, British Columbia, July 19, 2022 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva,” or the “Company”), a life science company with pharmaceutical... Read more
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals
Ryan Allway March 28th, 2022 News, Top News TEL AVIV, Israel and BETHESDA, Md., March 28, 2022 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has changed its corporate name to “CNBX Pharmaceuticals Inc.” CNBX Pharmaceuticals The Company’s new... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )